Pharma Industry News

New genetic test could pick out ‘high risk’ bone marrow cancer patients

Picking out patients whose cancers have high-risk genetic features could help clinicians realise sooner if they’re unlikely to respond to treatment, enabling them to find alternative options as early as possible.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]